Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 318 (RNA5SP318) is a genomic pseudogene—a non-coding DNA sequence derived from the 5S ribosomal RNA gene that has lost its original function due to mutations or genomic rearrangements[2][4]. Unlike the canonical 5S ribosomal RNA, which is an essential component of the large subunit of eukaryotic ribosomes and contributes to ribosomal structure and protein synthesis[1], RNA5SP318 does not produce a functional RNA product. Pseudogenes like RNA5SP318 may contribute to genome architecture or, rarely, gene regulation, but are generally not associated with cellular or therapeutic functions[4]. No known disease association, molecular function, or drug interaction is described for this pseudogene.
None. No drugs target RNA5SP318; no mechanism of action applies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 318 (RNA5SP318).